Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional)

The Tobacco Centers of Regulatory Science (TCORS) initiative, anticipated to be released in July 2026 by the National Institutes of Health in collaboration with the Food and Drug Administration’s Center for Tobacco Products, aims to fund multidisciplinary research centers focused on generating scientific evidence to inform tobacco product regulation and advance public health under the Family Smoking Prevention and Tobacco Control Act. These centers must encompass at least three distinct, hypothesis-driven research projects unified by an integrative scientific theme, with each project falling within the regulatory authority of the FDA CTP and addressing one or more key areas such as addiction, behavior, communications, health effects, impact analysis, marketing, product composition and design, or toxicity. Funding for this program will be administered by NIH using resources allocated through the FDA CTP and the FSPTCA, and applications may include clinical trials on an optional basis. The initiative emphasizes collaboration across disciplines to strengthen the evidence base supporting regulatory decision-making. The Tobacco Regulatory Science Program serves as the primary point of contact for inquiries, with all submissions and communications directed through the provided email address. The notice is currently forecasted and not yet open for submission, with no specific application deadline, set-aside classification, or NAICS code published at this stage.